Dried Blood Spot Multiplexed Steroid Profiling Using Liquid Chromatography Tandem Mass Spectrometry in Korean Neonates
1
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Background: Screening for congenital adrenal hyperplasia (CAH) using immunoassays for 17α-hydroxyprogesterone generates many false-positive results. We developed and validated a liquid chromatography–tandem mass spectrometry (LC-MS/MS) assay for simultaneous quantification of nine steroid hormones in dried blood spot (DBS) samples, and established reference intervals for these hormones. Methods: We examined our method for linearity, precision, accuracy, extraction recovery, and matrix effects and determined the reference intervals of cortisol, 17α-hydroxyproges-terone, 11-deoxycortisol, 21-deoxycortisol, androstenedione, corticosterone, 11-deoxycorticosterone, testosterone, and progesterone in 1,146 DBS samples (from 272 preterm and 874 full-term neonates). Immunoassay and LC-MS/MS methods were compared for 17α-hydroxyprogesterone. Fourteen additional samples were tested to validate the clinical applicability of the LC-MS/MS method. Results: The linearity range was 2.8–828.0 nmol/L for cortisol and 0.9–40.0 nmol/L for the other steroids (R2>0.99). Intra-day and inter-day precision CVs were 2.52–12.26% and 3.53–17.12%, respectively. Accuracy was 80.81–99.94%, and extraction recovery and matrix effects were 88.0–125.4% and 61.7–74.2%, respectively. There was a negative bias, with higher values measured by immunoassay compared with LC-MS/MS (r=0.8104, P< 0.0001). The LC-MS/MS method was successfully applied to the analysis of nine steroids in DBS for screening and diagnosis of CAH using the 14 additional samples. Conclusions: Our method enables highly sensitive and specific assessment of nine steroids from DBS and is a promising tool for clinical analysis of CAH.
Abstract
Background: Screening for congenital adrenal hyperplasia (CAH) using immunoassays for 17α-hydroxyprogesterone generates many false-positive results. We developed and validated a liquid chromatography–tandem mass spectrometry (LC-MS/MS) assay for simultaneous quantification of nine steroid hormones in dried blood spot (DBS) samples, and established reference intervals for these hormones. Methods: We examined our method for linearity, precision, accuracy, extraction recovery, and matrix effects and determined the reference intervals of cortisol, 17α-hydroxyproges-terone, 11-deoxycortisol, 21-deoxycortisol, androstenedione, corticosterone, 11-deoxycorticosterone, testosterone, and progesterone in 1,146 DBS samples (from 272 preterm and 874 full-term neonates). Immunoassay and LC-MS/MS methods were compared for 17α-hydroxyprogesterone. Fourteen additional samples were tested to validate the clinical applicability of the LC-MS/MS method. Results: The linearity range was 2.8–828.0 nmol/L for cortisol and 0.9–40.0 nmol/L for the other steroids (R2>0.99). Intra-day and inter-day precision CVs were 2.52–12.26% and 3.53–17.12%, respectively. Accuracy was 80.81–99.94%, and extraction recovery and matrix effects were 88.0–125.4% and 61.7–74.2%, respectively. There was a negative bias, with higher values measured by immunoassay compared with LC-MS/MS (r=0.8104, P< 0.0001). The LC-MS/MS method was successfully applied to the analysis of nine steroids in DBS for screening and diagnosis of CAH using the 14 additional samples. Conclusions: Our method enables highly sensitive and specific assessment of nine steroids from DBS and is a promising tool for clinical analysis of CAH.
참고문헌 (27)
- Rauh M, "Steroid measurement with LC-MS", MS in pediatric endocrinology, 2009, pp.301, 272~281
- Rossi C, "Serum steroid profiling for congenital adrenal hyperplasia using liquid chromatography-tandem mass spectrometry", Clin Chim Acta, 411, pp.222~228 (2010)
- Janzen N, "Rapid steroid hormone quantification for congenital adrenal hyperplasia(CAH)in dried blood spots using UPLC liquid chromatography-tandem mass spectrometry", Steroids, 76, pp.1437~1442 (2011)
- "NSQAP: Newborn Screening Quality Assurance Program. Laboratory Quality Assurance and Standardization Programs" (2018)[URL]
- Travers S, "Multiplexed steroid profiling of gluco-and mineralocorticoids pathways using a liquid chromatography tandem mass spectrometry method", J Steroid Biochem Mol Biol, 165, pp.202~211 (2017)
- 김보람, "Dried Blood Spot Testing for Seven Steroids Using Liquid Chromatography-Tandem Mass Spectrometry With Reference Interval Determination in the Korean Population", Annals of Laboratory Medicine, 35(6), pp.578~585 (2015), 대한진단검사의학회
- Seo JY, "Steroid profiling for congenital adrenal hyperplasia by tandem mass spectrometry as a second-tier test reduces follow-up burdens in a tertiary care hospital : a retrospective and prospective evaluation", J Perinat Med, 42, pp.121~127 (2014)
- Magnisali P, "Simultaneous quantification of 17α-OH progesterone, 11-deoxycortisol, Δ4-androstenedione, cortisol and cortisone in newborn blood spots using liquid chromatography-tandem mass spectrometry", J Chromatogr B Analyt Technol Biomed Life Sci, 879, pp.1565~1572 (2011)
- Horowitz GL, "Defining, establishing, and verifying reference intervals in the clinical laboratory, approved guideline. EP28-A3. 3rd ed", Clinical and Laboratory Standards Institute, ~ (2010)
- International Conference on Harmonisation (ICH), "ICH topic Q2 (R1) Validation of analytical procedures: text and methodology", Int Conf Harmon, 17~ (2005)
- Lacey JM, "Improved specificity of newborn screening for congenital adrenal hyperplasia by second-tier steroid profiling using tandem mass spectrometry", Clin Chem, 50, pp.621~625 (2004)
- "Bioanalytical method validation guidance for industry 2018" (2018)[URL]
- "Guideline on bioanalytical method validation" (2018)[URL]
- CLSI, "Evaluation of the linearity of quantitative measurement procedures: A statistical approach; approved guideline. CLSI document EP06A", Clinical and Laboratory Standards Institute, ~ (2003)
- CLSI, "Spectrometry for androgen and estrogen measurements in serum. CLSI guideline C57", Clinical and Laboratory Standards Institute, ~ (2015)
- CLSI, "Screening by tandem mass spectrometry. CLSI guideline NBS04. 2nd ed", Clinical and Laboratory Standards Institute, ~ (2017)
- CLSI, "Measurement procedure comparison and bias estimation using patient samples. CLSI guideline EP09c. 3rd ed", Clinical and Laboratory Standards Institute, ~ (2018)
- Dietzen DJ, "Dried blood spot reference intervals for steroids and amino acids in a neonatal cohort of the National Children’s Study", Clin Chem, 62, pp.1658~1667 (2016)
- "Republic of Korea. Guideline on Bioanalytical Method Validation 2013;12" (2018)[URL]
- Matuszewski BK, "Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS", MS, 2003, pp.75, 3019~3030
- Hicks RA, "Precursor-to-product ratios reflect biochemical phenotype in congenital adrenal hyperplasia", Metabolomics, 10, pp.123~131 (2014)
- "IUPAC Compendium of Chemical Terminology (The “Gold Book”). version 2.3.3" (2018)[URL]
- Janzen N, "Fast and direct quantification of adrenal steroids by tandem mass spectrometry in serum and dried blood spots", J Chromatogr B Analyt Technol Biomed Life Sci, 861, pp.117~122 (2008)
- Janzen N, "Newborn screening for congenital adrenal hyperplasia : additional steroid profile using liquid chromatography-tandem mass spectrometry", J Clin Endocrinol Metab, 92, pp.2581~2589 (2007)
- Boelen A, "Determination of a steroid profile in heel prick blood using LC-MS", MS, 2016, pp.8, 375~384
- Fiet J, "A liquid chromatography", tandem mass spectometry profile of 16 serum steroids, including 21-deoxycortisol and 21-deoxycorticosterone, for management of congenital adrenal hyperplasia, 2017, pp.1, 186~201
- Monostori P, "Concurrent confirmation and differential diagnosis of congenital adrenal hyperplasia from dried blood spots : application of a second-tier LC-MS", MS assay in a cross-border cooperation for newborn screening, 2015, pp.84, 311~318